Skip to main content

Scientist, Metabolism

NewLimit · NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

South San Francisco11-50 employeesPosted 11 days ago
Series C · $435Mraised 4 months agoled by Draper Associates, Founders Fund, Khosla Ventures

This board only lists companies whose most recent round closed in the last 180 days.

Apply on NewLimit’s site
<h1>Company info</h1> <p>NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.</p> <h1>Description</h1> <p>NewLimit is seeking an scientist with experience in liver biology and metabolism to join our Metabolism team. Our Metabolism team is developing reprogramming medicines to restore youthful function in aged hepatocytes in the context of metabolic disease. In this role, you will develop and perform assays for hepatocyte function, contribute to team decision making, and serve as a subject matter expert within NewLimit to enable our therapeutic development efforts.</p> <p>As a Scientist on our team, you will:</p> <ul> <li>Collaborate with our Single Cell Technology, Epigenetic Editing, and Predictive Modeling teams to design, build, and test epigenetic reprogramming interventions for aged and diseased hepatocytes</li> <li>Develop assays to preclinical models of liver disease to measure hepatocyte function</li> <li>Evaluate epigenetic reprogramming payloads using <em>in vivo</em> functional assays to select therapeutic candidates</li> <li>Deliver epigenetic reprogramming perturbations to hepatocytes in vivo using multiple transgenic manipulation methods (e.g. viral vectors, lipid nanoparticles)</li> <li>Analyze and interpret experimental data to drive pre-clinical decision making</li> </ul> <h1>Requirements</h1> <ul> <li>Ph.D. in cell biology, molecular biology, biochemistry or a related field or equivalent industry experience (5+ years)</li> <li>Experience with primary liver cell isolation and functional characterization</li> <li>Experience working with mouse models of liver dysfunction</li> <li>Experience with transgenic manipulation of liver cells either <em>ex vivo</em> <strong>or</strong> <em>in vivo</em> (e.g. using viral vectors, nucleic acid delivery)</li> <li>Exceptional organizational skills, including detailed experimental record-keeping and the ability to manage multiple concurrent project</li> </ul> <h1>Nice to have</h1> <ul> <li>History of contributing to a drug development program at the pre-clinical or clinical development stage</li> <li>Experience leading the design and execution of pre-clinical studies in mouse models</li> <li>Experience with single cell genomics methods</li> <li>Experience with pooled screening approaches using bulk or single cell read-outs (e.g. CRISPR fitness screens, Perturb/CROP-seq)</li> </ul> <h1>Benefits</h1> <p>NewLimit offers generous benefits to ensure our team can focus on our mission:</p> <ul> <li>Health, dental, and vision insurance</li> <li>401(k) with company match</li> <li>Paid parental leave</li> <li>Industry-leading paid time off (PTO) — 20 days/year for all employees + holidays</li> <li>Meals and snacks on-site</li> </ul> <p>Salary Range: $130,000 to $165,000. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Learn more at:&nbsp;<a href="https://www.newlimit.com/careers">https://www.newlimit.com/careers</a> &nbsp;</p> <p>*This compensation and benefits information is based on Company's good faith estimate as of the date of publication and may be modified in the future</p> <p>&nbsp;</p> <p>&nbsp;</p>
Apply on NewLimit’s site

Applications go straight to the employer. VCBacked does not sit between you and the company.

1,810 more roles posted in the last 48 hours

You are seeing the board after its 48-hour member window. Job Seeker opens that window and sends an alert the moment a role hits — applicants in the first 24 hours land 90 percent of interviews.

Back to all roles at freshly funded companies